Both in Surgical Instruments
West Pharmaceutical Services vs DexCom
Over the past year WST returned +45.5% and DXCM returned +37.3%; their daily moves had a correlation of 0.19.
WST +45.5% DXCM +37.3%Growth of $1, one year, split-adjusted
| Metric | WST | DXCM |
|---|---|---|
| Price | $406.99 | $82.97 |
| Market cap | $28.35B | $30.94B |
| Today | −0.22% | −2.11% |
| 1 month | +8.0% | −4.5% |
| 6 months | +31.3% | +39.5% |
| Year to date | +47.9% | +25.0% |
| 1 year | +44.3% | +42.5% |
| Revenue growth (YoY) | +8.7% | +11.2% |
| Gross margin | 39.7% | 64.3% |
| Net margin | 24.5% | 20.5% |
| P/E (TTM) | 44.4× | 31.2× |
| Price / sales | 8.3× | 6.1× |
| Net cash | $261.2M | $574.2M |
| Dividend yield | 0.22% | — |
| Volatility (60d) | 20.3% | 29.4% |
| Short % of float | 2.9% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).